{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:20:49Z","timestamp":1780446049662,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41390-023-02529-x","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T07:06:08Z","timestamp":1677308768000},"page":"1451-1455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["What are the key pediatric public policy priorities as the COVID-19 pandemic persists?"],"prefix":"10.1038","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2108-9433","authenticated-orcid":false,"given":"Mark R.","family":"Schleiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-4554","authenticated-orcid":false,"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-3205","authenticated-orcid":false,"given":"Chandy C.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"key":"2529_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/postgradmedj-2020-139070","volume":"97","author":"ST Liang","year":"2021","unstructured":"Liang, S. T., Liang, L. T. & Rosen, J. M. COVID-19: a comparison to the 1918 influenza and how we can defeat it. Postgrad. Med. J. 97, 273\u2013274 (2021).","journal-title":"Postgrad. Med. J."},{"key":"2529_CR2","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1016\/j.vaccine.2021.08.005","volume":"39","author":"MR Schleiss","year":"2021","unstructured":"Schleiss, M. R., John, C. C. & Permar, S. R. Children are the key to the Endgame: a case for routine pediatric COVID vaccination. Vaccine 39, 5333\u20135336 (2021).","journal-title":"Vaccine"},{"key":"2529_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein, L. R. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 383, 334\u2013346 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2529_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ped4.12232","volume":"4","author":"JA Blumenthal","year":"2020","unstructured":"Blumenthal, J. A. & Burns, J. P. Complexities of the COVID-19 vaccine and multisystem inflammatory syndrome in children. Pediatr. Investig. 4, 299\u2013300 (2020).","journal-title":"Pediatr. Investig."},{"key":"2529_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","volume":"71","author":"LD Zambrano","year":"2022","unstructured":"Zambrano, L. D. et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years \u2013 United States, July-December 2021. MMWR Morb. Mortal. Wkly Rep. 71, 52\u201358 (2022).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"2529_CR6","doi-asserted-by":"publisher","unstructured":"Bode, L. et al. Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection. Pediatr. Res. 1\u20138 https:\/\/doi.org\/10.1038\/s41390-022-02360-w (2022).","DOI":"10.1038\/s41390-022-02360-w"},{"key":"2529_CR7","doi-asserted-by":"publisher","unstructured":"Garai, R. et al. Clinical assessment of children with long COVID syndrome. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-022-02378-0 (2022).","DOI":"10.1038\/s41390-022-02378-0"},{"key":"2529_CR8","doi-asserted-by":"publisher","first-page":"n136","DOI":"10.1136\/bmj.n136","volume":"372","author":"W Shah","year":"2021","unstructured":"Shah, W., Hillman, T., Playford, E. D. & Hishmeh, L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 372, n136 (2021).","journal-title":"BMJ"},{"key":"2529_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","volume":"175","author":"J Villar","year":"2021","unstructured":"Villar, J. et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 175, 817\u2013826 (2021).","journal-title":"JAMA Pediatr."},{"key":"2529_CR10","doi-asserted-by":"publisher","first-page":"e009495","DOI":"10.1136\/bmjgh-2022-009495","volume":"8","author":"ER Smith","year":"2023","unstructured":"Smith, E. R. et al. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob. Health 8, e009495 (2023).","journal-title":"BMJ Glob. Health"},{"key":"2529_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2204399","volume":"387","author":"NB Halasa","year":"2022","unstructured":"Halasa, N. B. et al. Maternal vaccination and risk of hospitalization for COVID-19 among infants. N. Engl. J. Med. 387, 109\u2013119 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2529_CR12","doi-asserted-by":"publisher","first-page":"910138","DOI":"10.3389\/fimmu.2022.910138","volume":"13","author":"A Laguila Alto\u00e9","year":"2022","unstructured":"Laguila Alto\u00e9, A. et al. Vaccine protection through placenta and breastfeeding: the unmet topic in COVID-19 pandemic. Front. Immunol. 13, 910138 (2022).","journal-title":"Front. Immunol."},{"key":"2529_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/AOG.0000000000004661","volume":"139","author":"V Narayanaswamy","year":"2022","unstructured":"Narayanaswamy, V. et al. Neutralizing antibodies and cytokines in breast milk after coronavirus disease 2019 (COVID-19) mRNA vaccination. Obstet. Gynecol. 139, 181\u2013191 (2022).","journal-title":"Obstet. Gynecol."},{"key":"2529_CR14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jamapediatrics.2022.3581","volume":"176","author":"N Hanna","year":"2022","unstructured":"Hanna, N. et al. Detection of messenger RNA COVID-19 vaccines in human breast milk. JAMA Pediatr. 176, 1268\u20131270 (2022).","journal-title":"JAMA Pediatr."},{"key":"2529_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/d41586-022-00031-8","volume":"601","author":"S Hall","year":"2022","unstructured":"Hall, S. COVID vaccines safely protect pregnant people: the data are in. Nature 601, 308\u2013309 (2022).","journal-title":"Nature"},{"key":"2529_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/vaccines10050766","volume":"10","author":"P Galanis","year":"2022","unstructured":"Galanis, P. et al. Uptake of COVID-19 vaccines among pregnant women: a systematic review and meta-analysis. Vaccines (Basel) 10, 766 (2022).","journal-title":"Vaccines (Basel)"},{"key":"2529_CR17","doi-asserted-by":"publisher","first-page":"893292","DOI":"10.3389\/fmed.2022.893292","volume":"9","author":"FM Munoz","year":"2022","unstructured":"Munoz, F. M. et al. Preparing for disease X: ensuring vaccine equity for pregnant women in future pandemics. Front. Med. (Lausanne) 9, 893292 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"2529_CR18","doi-asserted-by":"crossref","unstructured":"Permar S, Creech CB, Edwards KM, Walter EB. Proposals to accelerate novel vaccine development for children. Pediatrics e2021054593 (2021).","DOI":"10.1542\/peds.2021-054593"},{"key":"2529_CR19","doi-asserted-by":"publisher","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-022-00846-2 (2023).","DOI":"10.1038\/s41579-022-00846-2"},{"key":"2529_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamapediatrics.2022.2800","volume":"176","author":"S Rao","year":"2022","unstructured":"Rao, S. et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 176, 1000\u20131009 (2022).","journal-title":"JAMA Pediatr."},{"key":"2529_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758\u2013763 (2022).","journal-title":"Nature"},{"key":"2529_CR22","doi-asserted-by":"publisher","first-page":"e1004122","DOI":"10.1371\/journal.pmed.1004122","volume":"19","author":"M Roessler","year":"2022","unstructured":"Roessler, M. et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 19, e1004122 (2022).","journal-title":"PLoS Med."},{"key":"2529_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.2022.11691","volume":"328","author":"E Azzolini","year":"2022","unstructured":"Azzolini, E. et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA 328, 676\u2013678 (2022).","journal-title":"JAMA"},{"key":"2529_CR24","doi-asserted-by":"publisher","first-page":"e069676","DOI":"10.1136\/bmj-2021-069676","volume":"377","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani, D. et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 377, e069676 (2022).","journal-title":"BMJ"},{"key":"2529_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.mm7201a1","volume":"72","author":"MR Valier","year":"2023","unstructured":"Valier, M. R. et al. Racial and ethnic differences in COVID-19 vaccination coverage among children and adolescents aged 5-17 years and parental intent to vaccinate their children \u2013 National Immunization Survey-Child COVID Module, United States, December 2020-September 2022. MMWR Morb. Mortal. Wkly Rep. 72, 1\u20138 (2023).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"2529_CR26","doi-asserted-by":"publisher","first-page":"e2021050531","DOI":"10.1542\/peds.2021-050531","volume":"147","author":"SA Plotkin","year":"2021","unstructured":"Plotkin, S. A. & Levy, O. Considering mandatory vaccination of children for COVID-19. Pediatrics 147, e2021050531 (2021).","journal-title":"Pediatrics"},{"key":"2529_CR27","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1016\/j.vaccine.2022.09.046","volume":"40","author":"D Romer","year":"2022","unstructured":"Romer, D., Winneg, K. M., Jamieson, P. E., Brensinger, C. & Jamieson, K. H. Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States. Vaccine 40, 6463\u20136470 (2022).","journal-title":"Vaccine"},{"key":"2529_CR28","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1542\/peds.2007-3218","volume":"122","author":"DJ Opel","year":"2008","unstructured":"Opel, D. J., Diekema, D. S. & Marcuse, E. K. A critique of criteria for evaluating vaccines for inclusion in mandatory school immunization programs. Pediatrics 122, e504\u2013e510 (2008).","journal-title":"Pediatrics"},{"key":"2529_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/acs.estlett.2c00350","volume":"9","author":"MK Wolfe","year":"2022","unstructured":"Wolfe, M. K. et al. Wastewater-based detection of two influenza outbreaks. Environ. Sci. Technol. Lett. 9, 687\u2013692 (2022).","journal-title":"Environ. Sci. Technol. Lett."},{"key":"2529_CR30","doi-asserted-by":"publisher","unstructured":"LeCroy, M. et al. Barriers to and solutions for representative inclusion across the lifespan and in life course research: the need for structural competency highlighted by the COVID-19 pandemic. J. Clin. Transl. Sci. 1\u201339. https:\/\/doi.org\/10.1017\/cts.2022.510 (2022).","DOI":"10.1017\/cts.2022.510"},{"key":"2529_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.15585\/mmwr.mm7116a1","volume":"71","author":"R Seither","year":"2022","unstructured":"Seither, R., Laury, J., Mugerwa-Kasujja, A., Knighton, C. L. & Black, C. L. Vaccination coverage with selected vaccines and exemption rates among children in kindergarten \u2013 United States, 2020-21 School Year. MMWR Morb. Mortal. Wkly Rep. 71, 561\u2013568 (2022).","journal-title":"MMWR Morb. Mortal. Wkly Rep."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02529-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T14:14:16Z","timestamp":1683728056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02529-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02529-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.R.S. is a consultant for Moderna vaccines. S.R.P. is a consultant for Pfizer, Moderna, Dynavax, Hoopika, and Merck CMV vaccines, and leads sponsored programs on CMV vaccines with Moderna and Dynavax. C.C.J. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}